Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Verve Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
VERV
Nasdaq
2836
www.vervetx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Verve Therapeutics, Inc.
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Feb 3rd, 2025 9:05 pm
Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
- Jan 29th, 2025 12:00 pm
Companies Like Verve Therapeutics (NASDAQ:VERV) Are In A Position To Invest In Growth
- Jan 27th, 2025 11:24 am
Verve Therapeutics (VERV) Moves 18.7% Higher: Will This Strength Last?
- Jan 23rd, 2025 2:31 pm
Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
- Jan 13th, 2025 12:00 pm
Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Jan 8th, 2025 12:00 pm
Why Is Verve Therapeutics, Inc. (VERV) Among the Top CRISPR Stocks to Invest In?
- Dec 30th, 2024 8:29 pm
Verve Therapeutics, Inc. (VERV): Is This Gene Therapy Stock a Good Buy Right Now?
- Dec 29th, 2024 11:34 am
Verve Therapeutics Slides As Insider Purchases Lose Another US$65k
- Dec 17th, 2024 10:08 am
Verve Therapeutics Third Quarter 2024 Earnings: Beats Expectations
- Nov 6th, 2024 12:53 pm
Verve Therapeutics (VERV) Reports Q3 Loss, Tops Revenue Estimates
- Nov 5th, 2024 1:15 pm
Verve Therapeutics: Q3 Earnings Snapshot
- Nov 5th, 2024 12:13 pm
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
- Nov 5th, 2024 12:00 pm
State Street Corp's Strategic Acquisition in Verve Therapeutics
- Oct 16th, 2024 9:01 pm
Is Verve Therapeutics, Inc. (VERV) the Best NASDAQ Stock Under $5?
- Oct 3rd, 2024 8:56 am
Jim Cramer on Vertiv Holdings (VRT): ‘I Think It’s A Winner’
- Sep 20th, 2024 8:40 pm
Millennium Management LLC's Strategic Acquisition in Verve Therapeutics Inc
- Sep 12th, 2024 5:15 am
Verve Therapeutics, Inc. (VERV): Among the Worst ARK Stocks According to Short Sellers
- Sep 8th, 2024 8:51 pm
Verve Therapeutics (VERV) Reports Q2 Loss, Lags Revenue Estimates
- Aug 8th, 2024 12:40 pm
Verve Therapeutics: Q2 Earnings Snapshot
- Aug 8th, 2024 11:47 am
Scroll